Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activated factor IX (factor IXa) is a serine protease enzyme that plays a central role in the blood coagulation cascade. It is the active form of coagulation factor IX, which circulates in plasma as an inactive zymogen until activated. FIXa forms a complex with calcium ions, membrane phospholipids, and activated cofactor VIIIa to efficiently catalyze conversion of inactive factor X to its active form Xa. Deficiency or dysfunction leads to hemophilia B.
Catalyzes conversion of inactive factor X to its active form Xa within the intrinsic tenase complex, leading to thrombin generation and fibrin clot formation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activated Factor IX (FIXa).